Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,987 JPY | +0.64% | -1.51% | +1.25% |
May. 22 | Japan's Nikkei stumbles as Nvidia earnings results loom | RE |
May. 20 | Japan's Nikkei retakes 39,000 level for first time since mid-April | RE |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's enterprise value to sales, at 4.17 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.25% | 75.22B | B | ||
-0.04% | 46.71B | A- | ||
+5.45% | 33.92B | C | ||
+11.23% | 18.2B | B | ||
+11.59% | 11.79B | A- | ||
-0.42% | 10.73B | - | ||
-21.10% | 10.2B | B | ||
+1.49% | 9.23B | A- | ||
-6.94% | 8.17B | C- | ||
-4.79% | 7.37B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4063 Stock
- Ratings Shin-Etsu Chemical Co., Ltd.